Sound waves could spot stroke dangers early

NCT ID NCT07013396

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 39 times

Summary

This study will use transcranial Doppler (TCD) ultrasound to measure blood flow in the brains of 100 people who had a stroke and underwent endovascular therapy (clot removal). The goal is to see if TCD readings can predict complications like bleeding or brain swelling in the days after treatment. Participants will have TCD exams daily for three days after their procedure. If TCD proves useful, it could help doctors catch problems earlier and improve recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Virginia Commonwealth University

    Richmond, Virginia, 23235, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

transcranial Doppler (TCD) ultrasound measurement

What this could lead to

If successful, this could help doctors identify stroke patients at risk of worsening after treatment, allowing earlier intervention and better outcomes.

What could go wrong

This is an early observational study with only 100 participants, so results may not apply to all stroke patients. TCD may not detect all complications.

Conditions

The condition(s) this trial relates to.

anterior cerebral artery infarction brain edema congestive heart failure coronary artery disorder diabetes mellitus Embolic Stroke heart failure intracranial embolism ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.